Shekhar Suman’s Post

Working on the General Pharma Legislation with EuropaBio - the European Association for Bioindustries team was and still is a valuable experience. 🩺 Proposing a revision of the #GPL after 20-year means a chance to strengthen European competitiveness in the development of cutting-edge therapies and medicines. 🏥 It is necessary to translate #EU market ambitions into concrete actions to reinforce the European biotech ecosystem, promoting innovation and ensuring effective and faster access to medicines. 🧬More #biotech innovations in the EU means more quality for EU healthcare systems. 🔗 If you want to read more about this: https://lnkd.in/d5Hs3f_U  

Last week at BioProcess International 2024 Hamza Patel and Ana-Maria Ionescu presented a poster with new data showcasing how IRO® has the potential to lower cost of goods (COGs) by up to 50%. When tested against a control manufacturing process, IRO achieved: 🔹 Higher CAR-T cell yield and improved transduction efficiency 🔹 Potent anti-tumor response 🔹 Shorter processing times Through its proprietary mixing protocols and automated fluid handling, IRO has demonstrated a significant reduction in the amount of viral vector and processing time needed to achieve the target CAR-T yield. We anticipate these reductions will lower process COGs by up to 50%. Reducing the COGs in cell therapy manufacturing is crucial to making these life-saving treatments more accessible and affordable for patients, supporting broader adoption and improving patient outcomes. 🔍 Want to learn more about the data? Read our poster ➡️ https://lnkd.in/eivWvCBR Or set up a partnering meeting at next week's Meeting on the Mesa, where we can share our COGs model, conduct a live demo of IRO, or discuss potential partnering opportunities ➡️ https://lnkd.in/e2n6wh3H #ManufacturingBrighterFutures #CellTherapy #GeneTherapy #PatientAccess #Biotechnology

Lab2Launch fuels commercialization during inaugural year! Lab2Launch is an incubator program supporting Emory-affiliated start-ups in therapeutics, diagnostics and imaging. It provides co-working and wet lab spaces alongside resources like Emory Integrated Core Facilities and Emory Healthcare. Start-ups benefit from business development support through partnerships with Biolocity, a joint Emory and Georgia Tech initiative. Lab2Launch accelerates biomedical start-ups with vital resources and support. Explore the incubator's first-year milestones ➡️ https://brnw.ch/21wPtlJ

Join Blake Mandell from Transcend Therapeutics at the upcoming Fierce Biotech Summit on Sept 30 - Oct 1 in Boston as he shares his expertise in groundbreaking biotech innovations and advancements. Register now and save up to $500 with the Early Bird Rate: https://ow.ly/uTAE50SyYgy Learn, Network and Connect over two jam-packed days with 500+ industry leaders and gain valuable insights into the future landscape of biotech. Stay Updated on all our events by following Fierce Life Sciences Events #FierceBiotechSummit #WeAreFierce #FierceBiotech #FierceBiotechSummit #BiotechInnovation #LifeSciences #PharmaIndustry #BiotechLeaders #Biotech2024 #BiotechTrends

This month our CEO, Charlie Peppiatt, and Prolight Diagnostics' Head of Engineering, Paul Monaghan, discussed our progress on the development of Psyros, an innovative point-of-care (POC) system, with BioStock - Connecting Innovation and Capital magazine. Prolight Diagnostics has enlisted G&H | ITL as partner for this project, aiming to revolutionize near-patient diagnostics by enabling quick, sensitive, and accurate testing of biomarkers, initially focusing on troponin for myocardial infarction detection. In the article, Charlie Peppiatt provides insight to our project roadmap, outlining the journey from developing the compact optical module to creating the prototype instrument, with plans for clinical validation studies in 2025. “Psyros is ushering in a new era of precision medicine, and we take pride in helping Prolight bring this diagnostic technology to market. This partnership exemplifies our joint commitment to advancing healthcare through cutting-edge innovation.” - Charlie Peppiatt, CEO of G&H. From concept to completion, we are proud to partner with Prolight Diagnostics as their end-to-end manufacturing partner. Read the full article: https://hubs.ly/Q02thhsR0 🖱 #ABetterWorldWithPhotonics #GHPhotonics #LifeScience #LifeSciences #Diagnostics #PointOfCareTesting #PointOfCare #MedTech #BioTechology

ATDBio × YouSeq: Accelerating Diagnostic Innovation 🧬 https://lnkd.in/eP263UpR We are thrilled to share how our oligonucleotides are helping power YouSeq's rapid success in molecular diagnostics, which was recently recognized in The Sunday Times Tech 100 list. 🏆 Hear from YouSeq founder Jim Wicks on how ATDBio's expertise in oligonucleotide chemistry enables our partners to develop cutting-edge diagnostic solutions that make a real difference in healthcare. 🔬

🚀 Nanobodies: The Future of Targeted Therapies and Diagnostics 🚀 #Nanobodies are revolutionizing precision medicine with their small, stable structure and faster, easier functionalization, enabling cost-effective, precise targeting for advanced drug delivery and diagnostics (https://lnkd.in/gtngY3n9). Compared to traditional antibodies, nanobody-based nanocarrier systems reduce functionalization time from 5 days to just 5 hours! To fully harness this potential, organizations need an efficient and reliable discovery process. That’s where Jotbody’s Nanobody #DiscoveryService comes in—offering a fast, customized approach to developing high-affinity nanobodies for specific targets. #NanobodyDiscovery #PrecisionMedicine #BiotechInnovation #AdvancedTherapies

At Sequence Biotech, we're dedicated to supporting your critical research efforts with our high-functioning pipettors designed to minimize downtime and keep operational costs low. Priced at $9,995.00 we are one of the most cost effective semi-automated benchtop pipettors on the market. ➡ High-throughput Pipettors: Our pipettors are engineered for precision and reliability, ensuring your experiments run smoothly and efficiently.   ➡ Minimizing Downtime: We understand that every second counts in the lab. Our semi-automated pipettors are built to perform consistently (some are still in the field +-1% accuracy after 12 years), reducing downtime and allowing you to focus on your research.   ➡ Cost-Efficiency: We are committed to providing cost-effective solutions. By minimizing maintenance and maximizing performance, we help keep operational costs for your lab tenants low without compromising quality. Upgrade your lab's efficiency and reliability with Sequence Biotech's cutting-edge pipettors. Let's work together to achieve groundbreaking results and drive innovation in biotechnology. Contact us today to discuss how our solutions can benefit your lab! MarathonLS Boston Lab Services GSK The Jackson Laboratory Labcorp National Cancer Institute (NCI) Pfizer Seagen GRAIL #LabEquipment #Pipettors #Biotechnology #LabEfficiency #SequenceBiotech #ResearchInnovation #CostEfficiency #LabManagers #SharedLabSpace #pipettor #consumables #NCI #grant #research

Advancing #Nanobody Discovery with Measurable Impact 🔬 How do you address the challenges of precision medicine with speed and efficiency? Nanobody technology is paving the way for breakthroughs in diagnostics, therapeutics, and advanced research. However, effectively harnessing this potential requires a robust, efficient discovery process. Jotbody’s Nanobody Discovery Service is designed to meet the demands of today’s biomedical landscape: • 12 weeks: A streamlined development process, reducing timelines by over 60%. • 20+ unique sequences: Sourced from camels, alpacas, llamas, and sharks for a comprehensive and diverse nanobody library. • Up to 40% cost savings: Optimized workflows to control expenses without compromising quality. • Targeted precision: Tailored nanobody solutions for challenging applications, including mutating pathogens and hard-to-reach molecular targets. 📊 With expertise in nanobody development, Jotbody helps you solve complex challenges efficiently, delivering measurable results to support your innovation. 👉 Learn more about our Nanobody Discovery Service here: https://lnkd.in/gkkpyWbU We welcome professionals in diagnostics, therapeutics, and research to connect and explore tailored solutions for their specific needs. #NanobodyDiscovery #PrecisionMedicine #BiotechInnovation #AdvancedResearch #Jotbody